Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Quanscient | $5,667,883 | (Nov 5, 2024)
Zing Dev Limited
United Kingdom
- London, England
- 02/05/2024
- Unknown
- $1,565,212
Zing is a Twilio Preferred Partner. We are dedicated to enabling organisations to deliver an extraordinary customer experience through the power of their Twilio services.
Built to Build: we work with Twilio’s cloud communications platform to bring all your conversations into one place, optimise workflows and give your agents the tools they need to provide amazing service.
From helping organisations move their communications to the cloud to implementing an omnichannel communications strategy, our team brings an agile methodology, advanced Twilio expertise and 100% commitment.
Headquartered in the UK and backed by Maven Capital Partners, Zing works with businesses and not-for-profits in the UK and across the Globe.
- Industry Software Development
- Website https://zing.dev/
- LinkedIn https://www.linkedin.com/company/zing-dev/
Related People
Julian HuckerFounder
United Kingdom -
London, England
CEO of Zing Dev Limited, entrepreneur, & optimist.
Built to Build: Zing is a Pure Play Preferred Twilio consulting partner. We are 100% focused on building solutions that enable organizations to deliver an extraordinary customer experience through the power of Twilio’s services. With backing from Maven Capital Partners, our plan is to create the leading Global Twilio Consulting Partner.
Previously I founded or co-founded a number of businesses including Esendex, now Commify, a major international provider of messaging services and ETE, a triathlon training company and pro-race team. I've also held several non-executive and mentoring roles with start-ups alongside a series of investments.
Miros | $6,535,520 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Further | $4,100,000 | (Nov 5, 2024)
Plato | $6,500,000 | (Nov 5, 2024)
cloudsquid | $1,000,000 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
Birl | $647,878 | (Nov 5, 2024)
Inquis Medical, Inc. | $40,000,000 | (Nov 5, 2024)
CrossBridge Bio | $10,000,000 | (Nov 5, 2024)